I-Mab Announces Selected Poster Presentation of CD73 Antibody Uliledlimab at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting

NEXT STORY
Global AI in Healthcare Market (2020 to 2025) – Featuring Intel, IBM & Google Among Others
PREV STORY
180 Life Sciences Corp. Congratulates Dr. Lynn Williams on International Dupuytren Award 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Relypsa Announces FDA Approval of Supplemental New Drug Application to Enable the Usage of Veltassa® (patiromer) With or Without Food

Updated label may allow for increased dosing flexibility for patients with hyperkalemia (elevated blood ...

author_avatar
NASDAQ Market News

Agios to Present at the 26th Annual Credit Suisse Healthcare Conference Tuesday, November 7, 2017

CAMBRIDGE, Mass., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader ...

author_avatar
NASDAQ Market News

Emergent BioSolutions to Release Second Quarter 2016 Financial Results and Conduct a Conference Call on August 4, 2016

GAITHERSBURG, Md., July 21, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host ...

author_avatar
NASDAQ Market News